logo

For the Inventor, By the Inventor

Mountain Lakes, NJ, United States of America

Robert E Manning

This inventor holds 10 USPTO granted patents. Top assignees: Sandoz Gmbh, Shandoz, Inc.. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert E Manning. Retrieved from https://idiyas.com/inventor/robert-e-manning-xdz1pnia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Mountain Lakes, NJ (US) (1976 - 1977)
  • Mt. Lakes, NJ (US) (1985)

Company Filing History:

goldMedal9 out of 1,603 
 
Sandoz Gmbh
 patents
silverMedal1 out of 1 
 
Shandoz, Inc.
 patent

Years Active: 1976-1985

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4544663 - Indolamine derivatives as anti-fertility agents (1985-10-01),
2. 4054665 - 2-Amino-5-(trifluoromethylphenylalkyl)-1,3,4 thiadiazoles used in the (1977-10-18),
3. 3992396 - 2-Amino-5-(substituted or unsubstituted phenylalkyl)-thiadiazoles (1976-11-16),
4. 3982020 - Substituted benzylidene hydrazines for treating hyperglycemia, obesity (1976-09-21),
5. 3978057 - Substituted amino-hydrazinopyridazines (1976-08-31),
6. 3974283 - N-substituted-4-T-butyl-1-pyridinethiocarboxamides and their use for (1976-08-10),
7. 3965110 - 2-Amino-5-(trifluoromethyl phenylalkyl)-1,3,4-thiadiazoles (1976-06-22),
8. 3963780 - N,N'-disubstituted-p-phenylenediamines (1976-06-15),
9. 3934034 - Hydroxy substituted diphenylalkyls for treatment of lipidemia (1976-01-20),
10. 3932481 - Sulfuric acid esters of bis-(4-hydroxyphenyl)-methane (1976-01-13),

Title: The Innovative Journey of Robert E. Manning

Introduction

Robert E. Manning, an esteemed inventor based in Mountain Lakes, New Jersey, has made significant contributions to the field of pharmaceuticals with a total of 10 patents. His inventive spirit and dedication to research have led to the development of important compounds that have applications in treatment contexts.

Latest Patents

One of his latest patents includes the invention of Indolamine derivatives as anti-fertility agents. This innovation explores the aspermatogenesis activity of 2-Amino-5-(trifluoromethylphenylalkyl)-1,3,4-thiadiazoles, focusing on compounds such as 2-amino-5-(3-trifluoromethylbenzyl)-1,3,4-thiadiazole. These compounds are synthesized through the ring closure of corresponding 1-(substituted or unsubstituted phenylalkanoyl)-thiosemicarbazide in a strong acid medium. The findings indicate that these derivatives are useful as minor tranquilizers and sleep inducers, showcasing Manning's remarkable ability to innovate in the pharmaceutical sector.

Career Highlights

Throughout his career, Robert E. Manning has worked with reputable companies including Sandoz GmbH and Shandoz, Inc. His experiences in these organizations have undoubtedly shaped his approaches to research and innovation, allowing him to focus on advancing therapeutic solutions.

Collaborations

Manning has collaborated with notable professionals such as Marcel K. Eberle and William J. Houlihan. These partnerships have enhanced his research endeavors and have contributed to his successful patent applications, reflecting the collaborative nature of scientific innovation.

Conclusion

In conclusion, Robert E. Manning exemplifies the spirit of innovation within the field of pharmaceuticals through his impactful patents and collaborations. His work continues to pave the way for novel applications that enhance healthcare solutions, showcasing the importance of inventors in advancing human knowledge and welfare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…